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Mutations in the lamin A/C (LMNA) gene that cause Hutchinson-Gilford progeria syndrome (HGPS)
lead to expression of a protein called progerin with 50 amino acids deleted from the tail of prelamin
A. In cells frompatientswith HGPS, both the amount and distribution of heterochromatin are altered.
We designed in vitro assays to ask whether such alterations might reﬂect changes in chromatin, DNA
and/or histone binding properties of progerin compared towild-type lamin C-terminal tails.We show
that progerin tail has a reduced DNA/chromatin binding capacity and modiﬁed trimethylated H3K27
binding pattern, offering a molecular mechanism for heterochromatin alterations related to HGPS.
Structured summary:
MINT-7893924, MINT-7893941, MINT-7893990, MINT-7894005, MINT-7894023, MINT-7894038: H3
(uniprotkb:Q71DI3) binds (MI:0407) to LaminA (uniprotkb:P02545) by surface plasmon resonance
(MI:0107)
MINT-7893957, MINT-7893974, MINT-7894055:H3 (uniprotkb:Q71DI3) binds (MI:0407) to progerin (uni-
protkb:Q6UYC3) by surface plasmon resonance (MI:0107)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction gene [6]. In Hutchinson-Gilford progeria syndrome (HGPS), cellsA-type and B-type lamins are nuclear intermediate ﬁlaments
that polymerize to form a meshwork between chromatin and the
inner nuclear membrane. A-type lamins are encoded by the lamin
A/C gene (LMNA) which generates lamins A and C by alternative
RNA splicing in most terminally differentiated cells [1], whereas
B-type lamins are encoded by two different genes (lamin B1 gene
(LMNB1) and lamin B2 gene (LMNB2)), which are expressed in all
or most somatic cells [2,3]. While few disorders are associated with
alterations in the LMNB1 and LMNB2 genes [4,5], a wide variety of
diseases including myopathies, lipodystrophies and premature
aging syndromes are caused by mutations throughout the LMNAchemical Societies. Published by E
ulfonyl ﬂuoride; aa, amino
T, glutathione S-transferase;
heterochromatin protein 1;
, lamin B2 gene; NLS, nuclear
aris-diderot.fr (I. Duband-express progerin, a prelamin A variant from which 50 amino acids
(aa) are deleted from the C-terminal tail (deletion aa 607–656)
[7,8]. We have previously shown that progerin disturbs the segre-
gation between A-type and B-type lamin homopolymers [9].
While the lamina is normally associated with chromatin in cells,
many studies have shown that wild-type lamins bind chromatin
in vitro [10–12]. However, in the pathological context of progeria,
the abnormal structure of the lamina has been correlated with a
loss of heterochromatin and perturbations in histones H3 and H4
epigenetic marks [13–15].
Here we asked whether the alterations of chromatin in cells
from patients with HGPS reﬂect alterations in the chromatin bind-
ing properties of progerin. While the nuclear localization signal
(NLS) region of lamins may represent a ‘‘basic binding motif” for
chromatin and histones [10–12], another chromatin binding site
has been suggested to reside in the C-terminal region of Xenopus
lamin A tail [16]. The corresponding region in human lamin A con-
tains the 50 aa deleted from progerin. To investigate the role of the
50 aa deleted in progerin in chromatin binding, we performed
in vitro assays with recombinant C-terminal domains (wild-typelsevier B.V. All rights reserved.
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cused on the intrinsic properties of the C-terminal lamin se-
quences, as no attempt to farnesylate recombinant prelamin A or
progerin tails was performed. We show that DNA/chromatin bind-
ing properties of the progerin tail are distinct from those of wild-
type A-type and B-type lamin tails.2. Materials and methods
Detailed procedures are given in the Supplementary data.
2.1. Preparations of histone complexes
Histone octamers used for dinucleosomes preparations were
puriﬁed from duck erythrocytes as described [17]. Instead, his-
tones H3, H4, H2A, H2B from calf thymus (Roche) used in glutathi-
one S-transferase (GST) pull-down experiments, were assembled in
histone octamers following a protocol adapted from two published
methods [18,19]. Histone octamers were stored at 80 C.
2.2. DNA and dinucleosomes preparations
The 357 base pairs (bp) and 146 bp DNA fragments were
puriﬁed, dephosphorylated and 50-end labeled with 32P-ATP as de-
scribed previously [20]. A dinucleosome preparation was obtained
by mixing 32P-DNA fragments of 357 bp and histone octamers with
a histone/DNA weight ratio of 1.5 [20].
2.3. Recombinant GST fusion proteins and peptides
cDNAs encoding the C-terminal tail of prelamin A, lamin A, lam-
in C, lamin B1 and progerin were cloned into pGEX-4T or pGEX-2T
vectors that encode GST. Escherichia coli strain BL21 was trans-
formed with the diverse plasmids. GST-HP1a construction was de-
scribed previously [21]. Expression and puriﬁcation of GST fusion
proteins were performed using Glutathione Sepharose 4B accord-
ing to manufacturer’s instructions (GE Healthcare, Bio-Sciences
AB, Sweden). Puriﬁed proteins were analyzed by SDS–PAGE and
their concentrations estimated after Coomassie blue staining. Pro-
tein aliquots were stored at 80 C.
Peptides corresponding to aa 1–20 and aa 17–31 of the N-termi-
nal tail of H3, and containing unmodiﬁed (H3K9; H3K27) or trime-
thylated lysines 9 and 27 (H3K9me3; H3K27me3), respectively,
(Peptide Specialty Laboratories, Heidelberg, Germany) were solubi-
lized at a concentration of 50 mg/ml in 50 mM Tris–HCl, pH8,
1 mM EDTA, 1 mM DTT, 1 mM 4-(2-aminoethyl)benzenesulfonyl
ﬂuoride (AEBSF), and 200 mM NaCl; peptide aliquots were stored
at 80 C.
2.4. Protein–DNA interactions and electrophoretic mobility shift assays
(EMSA)
Recombinant GST-lamin tails were diluted in a Tris–NaCl
buffer [10 mM Tris–HCl, pH 8, 50 mM NaCl, 1 mM EDTA, 0.1% Tri-
ton X-100 and 1 mM AEBSF], to different concentrations (21,
42, 84 and 168 nM for dinucleosome binding experiments and
26, 52, 104 and 208 nM for DNA binding experiments). They were
incubated at room temperature for 3 h with 32P-labeled DNA
fragments or reconstituted dinucleosomes (26 and 10.5 nM,
respectively).
For EMSA, protein–DNA complexes were analyzed on native
polyacrylamide gels and DNA retardation was detected as de-
scribed previously [20]. Measurements of the radioactive DNA sig-
nals were performed with a STORM 860 scanner (Amersham) using
the ImageQuant software (Molecular Dynamics, Inc.).2.5. GST pull-down assays
Recombinant GST-lamin tails, GST-HP1a or GST alone were
incubated with histone octamers in equal stoichiometry
(1.44 lM) in binding buffer [50 mM Tris–HCl, pH 8, 0.5% Triton
X-100, 1 mM AEBSF and 1 mM DTT] containing 200 mM NaCl for
3 h at 4 C. The complexes were mixed with Glutathione Sepharose
beads for one hour at 4 C and centrifuged at 800g for 5 min at
4 C. After six washes in binding buffer containing 300 mM NaCl,
the proteins bound to the beads were analyzed by 12.5% SDS–
PAGE. After proteins staining with SYPRO Ruby (Biorad), gels were
scanned on a Typhoon Trio scanner (GE Health Care) and signal
intensities were quantiﬁed using the Image J software.
2.6. Surface plasmon resonance experiment
Surface plasmon resonance (SPR) experiments were carried out
on a BIAcore 3000 (BIAcore, Uppsala, Sweden) using a hydrophobic
biosensor chip. Layouts of histone peptides diluted at 3 lM were
performed at 25 C in running buffer [4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 10 mM, pH 7.4, 150 mM NaCl].
Saturation coverage was obtained at 1200 resonance units (RU).
GST-C-ter lamins were injected at 5 nM to obtain complete satura-
tion. Kinetics analysis were performed by linearization using ‘‘ﬁt
kinetics Langmuir binding type” of BIAevaluation software, charac-
teristic of a simple bimolecular interaction. The association rate of
each protein was expressed as ng/mm2 since their irreversible
adsorption on histone peptides was not compatible with KD values
determination as discussed in [22].3. Results
3.1. Progerin tail has a binding afﬁnity for chromatin close to that of A-
type lamin tails, and much higher than that of lamin B1 tail
We ﬁrst compared the afﬁnities of A-type and B-type lamin tails
for chromatin. To do this, we prepared pure recombinant GST fu-
sion proteins containing the C-terminal tail of lamin A (aa 389–
646), prelamin A (aa 389–664), progerin (aa 389–D–664), lamin
C (aa 389–572), or lamin B1 (aa 391–586) (Fig. 1A and B). The pres-
ence of the region (aa 646–664) speciﬁc of prelamin A was con-
ﬁrmed by immunoblotting using anti-prelamin A antibodies
(Fig. 1C).
Dinucleosomes were used as chromatin sample. They were
incubated with increasing amounts of GST-lamin tails. Fig. 2 shows
formation of complexes with dinucleosomes that occurred with a
4-fold molar excess of GST-lamin A, GST-lamin C, GST-prelamin
A and GST-progerin tails whereas it required a 16-fold molar ex-
cess of GST-lamin B1 tail. No complex was detected with GST alone
(Fig. S1A). The binding efﬁciency of lamin tails to dinucleosomes
was in the order: lamin A and prelamin A > lamin C > progerin >>
lamin B1 (Fig. 2, graph). The KD values (Table 1) conﬁrmed that
prelamin A and lamin A tails afﬁnities for dinucleosomes (KD = 21
and 25 nM, respectively) were 2- to 3-fold higher than that of lam-
in C and progerin tails (KD = 53 and 73 nM, respectively), and 100-
fold higher than that of the lamin B1 tail (KD = 2 lM). While the
low afﬁnity of the lamin B1 tail for dinucleosomes clearly differen-
tiates it from A-type lamins, the progerin tail appears distinct with
an intermediate afﬁnity for dinucleosomes.
3.2. Progerin tail afﬁnity for DNA is close to that of B-type lamin tails,
and lower than that of A-type lamins
Increasing amounts of GST-lamin tails were incubated with a
146 bp DNA fragment. Fig. 3 shows that 4-fold molar excess of
Fig. 1. Puriﬁcation of proteins containing the C-terminal domains of A-type and B-
type lamins fused to GST. (A) Schematic representation of human lamin A
secondary structure. Downstream of the rod domain (dark gray boxes), the C-
terminal end contains the NLS (black boxes) and an Ig-like domain (Ig fold, streaked
boxes). Peptides of the C-terminal tails of A-type and B-type lamins used here,
lamin A (LA, aa 389–646), prelamin A (preLA, aa 389–664), progerin (Pgn, aa 389–
D–664), lamin C (LC, aa 389–572) and lamin B1 (LB1, aa 391–586) are indicated.
Positions of speciﬁc C-terminus of lamin C (aa 566–572) and the 50 amino acids
deletion in the progerin mutant (D607–656) are indicated. (B) Fusion proteins. GST-
C-ter lamin B1 (B1), lamin A (A), lamin C (C), prelamin A (pA), and progerin (Pgn)
were resolved by SDS–PAGE and stained with Coomassie blue. (C) Immunoblotting
analysis of the GST-C-ter prelamin A (pA). Samples containing 100 ng of GST-C-ter
pA were analyzed by 12.5% SDS–PAGE followed by immunoblotting using either
rabbit polyclonal antibodies directed against the NLS of lamin A/C (aNLS) or goat
antibodies raised against the last amino acids of WT prelamin A (a pA).
Table 1
Binding afﬁnities (KD) of the C-terminal tails of lamins for DNA and dinucleosomes.
* **
***
*
Free and bound 32P DNA signals were quantiﬁed for 2 molar excess (DNA-lamin
curves, Fig. 3) and 4 molar excess (diN-lamin curves, Fig. 2) of lamin tails. The
dissociation constant KD was calculated using the equation KD = ([D]  [DP])
([P]  [DP])/[DP]), where [D] is the total DNA concentration, [P] the total protein
concentration, and [DP] the protein-DNA complex concentration. The mean values
obtained from three or four independent experiments are presented with standard
deviations. (* and **) correspond to signiﬁcant differences P < 0.01 and P < 0.001,
respectively (Student t-test).
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to complex all DNA, whereas 8-fold molar excess of GST-progerin
tail was required to complex 90% of DNA. GST-lamin B1 failed toFig. 2. The C-terminal domains of lamin isoforms bind dinucleosomes (diN) with differe
(lanes 0) or presence (lanes 2, 4, 8 and 16) of increasing molar excess of GST-fusion pro
progerin. Complexes were resolved on a 5% non-denaturing polyacrylamide gel and sign
percentage of labeled diN bound to the GST-C-ter lamins (B/T) plotted as a function of thesaturate DNA. No complex was detected with GST alone
(Fig. S1B). The binding efﬁciencies of lamin tails to DNA (Fig. 3,
graph) were in the following order: lamin A, prelamin A and lamin
C > progerin > lamin B1. KD values (Table 1) conﬁrmed that prelam-
in A, lamin A and lamin C tails afﬁnities for DNA (KD = 13, 8 and
11 nM, respectively) were 5- to 10-fold higher than those deter-
mined for progerin and lamin B1 tails (KD = 67 and 80 nM, respec-
tively). Thus, afﬁnity of the progerin tail for DNA appears close to
that of the lamin B1 tail.
3.3. Progerin tail interaction with histone octamers is similar to that of
A-type lamins, and higher to that of B-type lamins
Fig. 4 shows that, as the control HP1a (lane 2), A-type lamin
tails including progerin were more efﬁcient than the lamin B1 tail
to bind histones octamers (Fig. 4, lanes 3–7 and graph). Thus, the
histone octamer binding capacity of the progerin tail appeared clo-
ser to that of A-type lamins. These results show that when com-
pared to A-type lamins, the low binding of lamin B1 tail to
chromatin (dinucleosomes) relies on a weaker interaction with
both DNA and histone octamers, whereas the intermediate binding
of progerin tail to chromatin relies mainly on a weaker interactionnt efﬁciencies. The 32P-radiolabeled dinucleosomes were incubated in the absence
teins containing the C-terminal tails of lamin A, lamin C, lamin B1, prelamin A, and
als revealed by autoradiography. D refers to naked DNA. The graph represents the
molar excess of the GST-C-ter lamins. Vertical bars indicated the standard deviation.
Fig. 3. The C-terminal domains of lamin isoforms bind DNA with different efﬁciencies. A 146 bp 32P-radiolabeled DNA fragment was incubated in the absence (lanes 0) or
presence (lanes 1, 2, 4, and 8) of increasing molar excess of GST-C-ter lamin A, GST-C-ter lamin C, GST-C-ter lamin B1, GST-C-ter prelamin A, and GST-C-ter progerin. The
complexes were resolved on a 4% non-denaturing polyacrylamide gel and the signals revealed by autoradiography. The percentage of labeled DNA bound to the GST-C-ter
lamins (B/T) was plotted as a function of the molar excess of the GST-C-ter lamins. Vertical bars indicated the standard deviation.
Fig. 4. The C-terminal domains of lamin isoforms bind the histone octamers. GST-fusion proteins containing the C-terminal tails of lamin A (A), lamin C (C), prelamin A (pA),
progerin (Pgn), and lamin B1 (B1), HP1a or GST protein alone (GST), were incubated with histone octamers. The pulled down complexes were separated by SDS–PAGE. Sample
loaded in lane 8 represent 20% of the input. Data presented in the graph are the mean values of signal intensities of pulled down octamers expressed as arbitrary units and
correspond to three independent experiments. Background values corresponding to octamers pulled down by GST were subtracted. Vertical bars indicate the standard
deviation. (*) corresponds to signiﬁcant difference P < 0.01 (Student t-test).
Fig. 5. Adsorption density of GST-C-ter progerin, prelamin A, and lamin A on
peptides encoding histone N-terminal tails bearing speciﬁc epigenetic modiﬁca-
tions. The adsorption density of the GST-C-ter progerin (Pgn), prelamin A (pA) and
lamin A (LA) tails on the trimethylated (me3) H3K9 or H3K27 and unmodiﬁed (Un)
H3K27 peptides was expressed as ng/mm2. Vertical bars indicate standard errors.
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unknown, our chromatin binding assay cannot address the effects
of epigenetic modiﬁcation of chromatin on lamin binding.
3.4. Role of epigenetic marks on histone H3 in the binding of progerin
tail to histones
A global loss of peripheral heterochromatin correlated with loss
of trimethylated H3K9 and H3K27 (markers of constitutive and
facultative heterochromatin, respectively) has been reported in
cells from patients with progeria [13–15]. As lamins bind to his-
tones, we reasoned that distribution of these modiﬁed histones
may be inﬂuenced by their local association with speciﬁc lamin
isoforms. We asked whether progerin that accumulates abnor-
mally in progeria, would have a reduced capacity to recognize
these epigenetic marks and thus contribute to their instability
and progressive loss.
Interactions of GST-C-ter lamin tails to peptides mimicking the
trimethylation of H3K9 and H3K27 versus the unmodiﬁed H3K27
peptide were investigated using surface plasmon resonance exper-
iments (SPR) and reported as adsorption densities of the lamin tailsexpressed in ng/mm2. Fig. 5 shows that the H3 peptide (aa 1–20)
trimethylated on K9 bound slightly more efﬁciently GST-C-ter
progerin than GST-C-ter lamin A. However, the binding capacities
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were similar. The H3 peptide (aa 17–31) trimethylated on K27
bound less efﬁciently GST-C-ter progerin than GST-C-ter prelamin
A and GST-C-ter lamin A. Interestingly, the unmodiﬁed H3 peptide
(aa 17–31) presented the same lamin binding capacities as the
K27me3 corresponding peptide. We conclude that, due to its de-
leted C-terminal region, progerin has an abnormally reduced capac-
ity to bind the H3 peptide (aa 17–31), which occurs independently
of the H3 trimethylation on K27, whereas it keeps a high capacity to
bind the H3 peptide (aa 1–20) that bears trimethylation on K9.4. Discussion
We have demonstrated differences between A-type and B-type
lamin tails in their DNA, histone and chromatin binding properties
in vitro. In vivo, one cannot exclude that these differences may be
modulated by the contribution of the N-terminal and/or the rod
domains of lamins in binding to DNA or histones. Nevertheless,
these results can provide a mechanistic explanation for the non-
redundancy of the roles of A-type and B-type lamins in chromatin
organization in cells. Compared to A-type lamins, progerin has two
distinct features. First, it remains farnesylated in cells and second,
it lacks 50 aa within the tail. These two features likely contribute to
the HGPS phenotype both by impeding the normal assembly of the
nuclear envelope associated lamina [9] and by disturbing the chro-
matin organization [13–15]. It has been shown that the toxicity of
the progerin is not restricted to its farnesylation status [23] sug-
gesting that the deletion of 50 aa might have an impact on interac-
tions with speciﬁc chromatin partners.
We have shown that the DNA/chromatin binding properties of
non-farnesylated progerin tail in vitro are reduced in comparison
to wild-type A-type lamin tails. We conclude that the amino acid
stretch (aa 607–646) of lamin A constitutes a binding site for
DNA and chromatin. However, progerin still retains some capacity
to bind DNA, histones and chromatin due to the presence of a basal
binding site located in the basic NLS region (aa 389–422) as previ-
ously shown [10–12]. We propose that the amino acid sequence
(aa 607–646) enhance the interaction of lamin A and prelamin A
with DNA/chromatin. A weaker DNA binding afﬁnity was found
for the minimal Ig-fold lamin domain (aa 411–553) in our previous
study [20] which may be related to the absence of the amino acid
sequence (aa 607–646) as well as to a partial deletion (aa 389–411)
of the basal binding site mentioned above. In addition, we could
not exclude that the GST-C-ter lamin tails dimerized through their
GST moiety in reduced conditions may favor DNA binding com-
pared to Ig-fold lamin dimers formed in the absence of DTT by for-
mation of a disulﬁde bond through cysteine 522 [20].
Our experiments with histone H3 peptides with or without epi-
genetic modiﬁcations highlighted that, in comparison to wild-type
immature and mature lamin A, progerin bound less efﬁciently the
H3 peptide sequence (aa 17–30), either unmodiﬁed or trimethylat-
ed on K27. This suggest that the H3 sequence (aa 17–30) would
contain a binding element for wild-type lamin A and that the lamin
region (aa 607–656) that is deleted in progerin, largely contributes
to the interaction with the H3 region (aa 17–30). In HGPS cells, it
was reported that the decrease in H3K27me3 is an initial event
that precedes the reduced amount of heterochromatin and its loss
of interaction with the lamina [14]. Extrapolating our in vitro data
to the situation reported in cells, we propose that the mechanism
by which the amount of H3K27me3 decreases could result from
the inability of progerin to bind and stabilize this mark efﬁciently.
In contrast, the remodeling of heterochromatin in HGPS cells
would not rely on a loss of interaction of H3K9me3 mark with
progerin. In conclusion, our data illustrate the extent to which
the non-farnesylated progerin tail has in vitro chromatin bindingproperties distinct from both A-type and B-type lamin tails, thus
offering a molecular explanation for the heterochromatin altera-
tions induced by progerin in HGPS cells.
Our in vitro studies were limited to non-farnesylated progerin,
whereas in cells of human subjects with HGPS progerin is farnesy-
lated. In this regard, it is important to note that non-farnesylated
progerin elicits disease in a mouse model of HGPS, although the
phenotype appears milder than if farnesylated progerin is ex-
pressed [23]. Furthermore, while treatment with protein farnesyl-
transferase inhibitors of mice with a genetically engineered HGPS
mutation improves the progeroid phenotype, it does not com-
pletely reverse it [24]. Our experiments on non-farnesylated prog-
erin therefore have relevance to the pathogenesis of HGPS and
further suggest that blocking farnesylation of progerin may not
be a ‘‘cure” for HGPS as the non-farnesylated protein has abnormal
DNA/chromatin binding properties.
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